Recommendations made out-of-session by the PBAC between March 2023 and July 2023 meetings

10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available. ...

Read more →

Agenda for the May 2023 intracycle meeting

28 April 2023 - The agenda for the May 2023 PBAC intracycle meeting is now available. ...

Read more →

Recommendations made by the PBAC (March 2023)

21 April 2023 - Recommendations made by the PBAC in March 2023 relating to the listing of medicines on the Pharmaceutical ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee – March and April 2023

20 April 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 24 March 2023 and ...

Read more →

HTA reform starts today – consultations open

11 April 2023 - Medicines Australia welcomes the official start of the Health Technology Assessment (HTA) Review consultation that should ...

Read more →

Health technology assessment policy and methods review consultation

11 April 2023 - The first round of public consultation for the HTA Review is open. Submissions will be accepted ...

Read more →

Public summary documents – December 2022 PBAC meeting

6 April 2023 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the December 2022 PBAC ...

Read more →

Agenda for the July 2023 PBAC meeting

29 March 2023 - The agenda for the July 2023 PBAC meeting is now available. ...

Read more →

HTA reform gets underway – terms of reference released today

22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...

Read more →

Terms of reference for the Health Technology Assessment Policy and Methods Review

22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) - November 2022 PBAC meeting

17 March 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2022 PBAC ...

Read more →

CEO’s appointment to HTA Review Reference Committee

15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (March 2023)

9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023.  ...

Read more →

DoH makes further tweaks to the agenda for this week's PBAC meeting

7 March 2023 - We are now at version 4 with four revisions. ...

Read more →

Public Summary Documents – November 2022 PBAC meeting (round 1)

3 March 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2022 PBAC ...

Read more →